Related Experiment Video
Updated: Jul 15, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
Pharmacokinetics of olsalazine and its metabolites
1Ziekenzorg, Enschede, The Netherlands.
Abstract:
After a single dose of olsalazine, the maximum serum concentration of the intact compound is much lower than after an equivalent dose of sulphasalazine. In both compounds the diazo bond is largely split by colonic bacteria and comparable amounts of the metabolites 5-ASA and acetyl-5-ASA are recovered in the faeces. During long-term ingestion of olsalazine, 1-4 weeks are required to reach a steady state, and serum concentrations of the parent drug are low. It is demonstrated that olsalazine is rapidly sulphated into the metabolite, olsalazine-O-sulphate, which has a long half-life. Acetyl-5-ASA is more stable and more soluble than 5-ASA; however, the therapeutic efficacy of acetyl-5-ASA in inflammatory bowel disease is not proven.
Related Concept Videos
Pharmacokinetics: Overview
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

